Home
About
Overview
Sharing Data
ORCID
Help
History (22)
High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury.
Multiple skull base defects in the setting of spontaneous cerebrospinal fluid rhinorrhea; a dual institution view.
Memory for Serial Order in Alzheimer's Disease and Vascular Dementia: A Competitive Queuing Analysis.
Osteoarthritis pain: What are we learning from animal models?
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018 04; 17(4):280-299.
View in:
PubMed
subject areas
Animals
Clinical Trials as Topic
Drug Evaluation, Preclinical
Fragile X Syndrome
Humans
Neurodevelopmental Disorders
Neurotransmitter Agents
Randomized Controlled Trials as Topic
authors with profiles
Elizabeth M Berry-Kravis